<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04036812</url>
  </required_header>
  <id_info>
    <org_study_id>2019-06-29</org_study_id>
    <nct_id>NCT04036812</nct_id>
  </id_info>
  <brief_title>Superficial Cervical Plexus Block for Postoperative Analgesia</brief_title>
  <official_title>Ultrasound Guided Superficial Cervical Plexus Block for Analgesia After Craniotomy Via Suboccipital Retrosigmoid Approach: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Tiantan Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Tiantan Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The incidence of postoperative pain after craniotomy is high. Severe postoperative pain can&#xD;
      lead to a series of complications that are detrimental to the recovery of craniotomy&#xD;
      patients. Compound local scalp nerve block is a good choice for analgesia after craniotomy.&#xD;
      However, the scalp nerve block commonly cannot cover the area of suboccipital retrosigmoid&#xD;
      approach craniotomy, leading to incomplete block. Superficial cervical plexus block (SCPB) is&#xD;
      theoretically promising to solve the analgesia requirements of such surgical approach. At the&#xD;
      same time, ultrasound guidance can not only accurately locate, ensure the effect of block and&#xD;
      avoid accidental injury during puncture. The purpose of this study is to explore whether&#xD;
      ultrasound-guided superficial cervical plexus block can safely and effectively reduce the&#xD;
      requirement of analgesic drugs and pain after craniotomy via suboccipital retrosigmoid&#xD;
      approach.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 18, 2019</start_date>
  <completion_date type="Anticipated">March 8, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 8, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the cumulative consumption of sufentanil by the PCA</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>the cumulative consumption of sufentanil by the PCA 24 hours after surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Use of analgesics by the PCA after operation</measure>
    <time_frame>at 1, 2, 4, 48 hours after surgery.</time_frame>
    <description>the cumulative consumption of sufentanil by PCA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain severity score</measure>
    <time_frame>at 1, 2, 4, 24, 48 hours after surgery</time_frame>
    <description>It will be accessed using NRS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anesthesia recovery quality scoreï¼š</measure>
    <time_frame>at 1 hour after surgery</time_frame>
    <description>It will be accessed at postoperative 1 and 2 hours using the Anesthesia Steward Emergence Scale. The Anesthesia Steward Emergence Scale(0-6) is divided into three parts: the degree of wakefulness - 2 points for complete recovery, 1 point for response to stimulation, 0 point for no response to stimulation; the degree of airway patency - 2 points for cough according to the doctor's order, 1 point for maintenance of airway patency without support, 0 point for support required for respiratory tract; 2 points for conscious activities of limbs with limb mobility, 1 point for unconscious activities of limbs, point for no activities of limbs.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient analgesic satisfaction</measure>
    <time_frame>at 24 hours after surgery</time_frame>
    <description>Patient satisfaction with overall pain management will be evaluated at 24 hours after surgery using NRS</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">106</enrollment>
  <condition>Plexus Block;Analgesia;Neurosurgery</condition>
  <arm_group>
    <arm_group_label>Superficial cervical plexus block group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Superficial cervical plexus block</intervention_name>
    <description>superficial cervical plexus nerve block will be performed under the guidance of ultrasound</description>
    <arm_group_label>Superficial cervical plexus block group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control group</intervention_name>
    <description>ultrasound guidance will be used to determine the location of superficial cervical plexus nerve. The puncture will also be performed by ultrasound guidance, covered with opaque infusion dressing but performed with infusion of 10 ml normal saline.</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Elective suboccipital retrosigmoid approach approach craniotomy;&#xD;
&#xD;
          2. Age between 18 and 65 years;&#xD;
&#xD;
          3. American Society of Anesthesiologists (ASA) physical status I-III.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. The patients or legal clients refuse to provide informed consent;&#xD;
&#xD;
          2. Local infection;&#xD;
&#xD;
          3. Preoperative impairment of consciousness and cognitive function;&#xD;
&#xD;
          4. Uncontrolled hypertension;&#xD;
&#xD;
          5. Inability to communicate;&#xD;
&#xD;
          6. Allergies to experimental drugs;&#xD;
&#xD;
          7. History of drug abuse;&#xD;
&#xD;
          8. History of chronic headache;&#xD;
&#xD;
          9. Aphasia and hearing impairment;&#xD;
&#xD;
         10. Patients undergoing second craniotomy;&#xD;
&#xD;
         11. Body mass index &lt; 18.5 kg/m2 or &gt; 35.0 kg/m2;&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yuming Peng, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beijing Tian Tan Hospital, Capital Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yuming Peng, M.D.</last_name>
    <phone>010-59976658</phone>
    <email>florapym766@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Beijing Tiantan Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100050</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuming Peng, M.D.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Beijing TianTan Hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100070</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>July 26, 2019</study_first_submitted>
  <study_first_submitted_qc>July 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 30, 2019</study_first_posted>
  <last_update_submitted>September 9, 2021</last_update_submitted>
  <last_update_submitted_qc>September 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Tiantan Hospital</investigator_affiliation>
    <investigator_full_name>Yuming Peng</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Agnosia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

